Using UNC's expertise to fight emerging diseases
Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that.
(UNC.edu)
Related: Campus Connections
Lucas: Eric Church’s public service makes him ideal for UNC's 2026 CommencementEric Church has been all over the world. He’s played the biggest stages in music. He’s hosted the largest concert in North Carolina’s history. He’s...
Wed Oct 1, 2025Country star Eric Church is UNC's 2026 Spring Commencement speaker
World-renowned country musician and avid Tar Heel fan Eric Church will deliver Carolina's 2026 Spring Commencement address. The ceremony will be held in Kenan Stadium...
Wed Oct 1, 2025
UNC alum, legendary sportscaster Marty Brennaman immortalized with statue at Reds' stadium
Marty Brennaman has been inducted into the Baseball Hall of Fame, the Reds Hall of Fame and the Sportscasters and Sportswriters Hall of Fame, but...
Wed Oct 1, 2025
Seven Tar Heels selected for 2025 Distinguished Alumni Awards
Each University Day, UNC honors alumni for their outstanding contributions to UNC and society. This year, the University will present seven Distinguished Alumni Awards at...
Mon Sep 29, 2025